AbbVie Inc. News - ABBV

Kaufen
Verkaufen
Best deals to access real time data!
Trade Alert US
Monthly Subscription
for only
52,79 €
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
US Markets and Indices (NYSE/NASDAQ/AMEX/DowJones/S&P)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp ISIN Beschreibung
AbbVie Inc. ABBV NYSE Ordinary Share
  Änderung Änderung % Aktuell Hoch Niedrig Handelsbeginn Handelsende Zeit
  -0,26 -0,33% 78,69 79,34 78,21 78,95 78,95 05:59:53
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.6.201900:00PRNUSNew Long-Term Data from Upadacitinib Phase 3 Studies in..
11.6.201913:00PRNUSNew Two-Year Data at the 24th World Congress of Dermatology..
10.6.201914:00PRNCAAbbVie's MAVIRET™ now listed on the Nova Scotia and Manitoba..
07.6.201914:00PRNUSAbbVie to Present at the Goldman Sachs Global Healthcare..
06.6.201915:00PRNCAAbbVie Receives Positive Recommendation from the..
04.6.201917:09PRNUSAbbVie Presents Data from Venetoclax Chemotherapy-Free..
31.5.201923:01EDGARSpecialized Disclosure Report (sd)
30.5.201914:45PRNUSAbbVie Presents Results from Several Studies and Clinical..
30.5.201914:00PRNCAAbbVie's MAVIRET™ now listed in New Brunswick
29.5.201920:30DJNJohnson & Johnson Weighs on Pharmaceutical ETFs
23.5.201915:00PRNCAAbbVie reaches an agreement with the pan-Canadian..
21.5.201914:00PRNCAAbbVie Launches ORILISSA™ (elagolix) 200 mg BID Dose for the..
17.5.201915:31DJNAbbVie Glioblastoma Drug Misses Primary Endpoint
17.5.201914:45PRNUSAbbVie Provides Update on Depatuxizumab Mafodotin..
15.5.201921:30DJNGenentech Says FDA Approves Venclexta Plus Gazyva for..
15.5.201920:19PRNUSAbbVie Announces US FDA Approval of VENCLEXTA® (venetoclax)..
15.5.201909:02DJNDrugmakers Settle U.S. Patent Dispute Over Clone of Humira..
14.5.201918:16DJNAbbVie, Boehringer Ingelheim in U.S. Settlement on Humira..
14.5.201916:13BWMC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials..
14.5.201915:53DJNAbbVie, Boehringer Ingelheim in U.S. Settlement on Humira..
14.5.201914:34PRNUSAbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation..
14.5.201914:00PRNUSAbbVie to Present at the UBS Global Healthcare Conference
08.5.201923:45DJNDrug Prices to Be Disclosed in TV Ads Soon -- Update
08.5.201919:38DJNDrug Prices to Be Disclosed in TV Ads Soon
07.5.201922:57EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:57EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:57EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:56EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:55EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:55EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:54EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:54EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:51EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201922:50EDGARStatement of Changes in Beneficial Ownership (4)
07.5.201914:00PRNUSAbbVie to Present at the Bank of America Merrill Lynch..
06.5.201923:13EDGARCurrent Report Filing (8-k)
06.5.201912:30GLOBEAlector Announces First Alzheimer’s Disease Patient Dosed in..
03.5.201916:29EDGARQuarterly Report (10-q)
30.4.201920:57DJNFDA Approves AbbVie's Mavyret for All Genotypes of Hepatitis..
30.4.201919:49DJNAbbVie Gets European Commission Approval of Skyrizi in..
30.4.201913:45PRNUSEuropean Commission Approves SKYRIZI™ (risankizumab) for the..
30.4.201913:08PRNUSAbbVie to Present New and Updated Data of Investigational..
25.4.201914:43DJNAbbVie Raises Adjusted Profit Guidance
25.4.201913:46EDGARCurrent Report Filing (8-k)
25.4.201913:42PRNUSAbbVie Reports First-Quarter 2019 Financial Results
24.4.201900:19PRNUSAbbVie Expands Immunology Portfolio in the U.S. with FDA..
23.4.201921:22DJNTrovagene Shares Rising Tuesday Following Preclinical Data..
18.4.201916:05PRNCASanté Canada approuve SKYRIZIMC (risankizumab) pour le..
17.4.201919:48EDGARNotice of Exempt Solicitation. Definitive Material...
11.4.201915:00PRNCAMAVIRET(MC) d'AbbVie maintenant remboursé au Québec
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
NYSE
ABBV
AbbVie Inc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20190616 20:40:52